Hemophilia A

Hemophilia A is the indication for 15 drugs in DrugBank. It is covered by 35 curated, structured indications.

Also known as: Haemophilia A · Congenital Hemophilia A · Hemophilia A, Congenital · Autosomal Hemophilia A · Classic Hemophilia
Classified under: Cardiovascular Diseases
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hemic and Lymphatic Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Antihemophilic factor (recombinant), PEGylated
Antihemophilic factor human
Antihemophilic factor, human recombinant
Beroctocog alfa
Coagulation factor VIIa Recombinant Human
Concizumab
Damoctocog alfa pegol
Desmopressin
Efanesoctocog alfa
Efmoroctocog alfa
Factor IX Complex (Human)
Lonoctocog alfa
Susoctocog alfa
Turoctocog alfa
Von Willebrand factor human

Resolves to

Vocabularies

MeSHM0010149ICD-10D66SNOMED CT154816002MedDRA10010468UMLSC0019069

What you can answer from here — as of October 25, 2026

15Indicated drugsWith each drug's targets and mechanism

Listed above

35Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

514Clinical trialsPhase, status and sponsor resolved per trial

4Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Hemophilia A share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.